Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-25-000201·MORGAN STANLEY
Schedule 13G ownership disclosure
Treace Medical Concepts Inc
Common Stock · CUSIP: 89455T109
Event date: 2024-12-31
- Filing-level shares
- 2,091,809
- Percent of class
- 3.4%
- Morgan Stanley
Shares: 2,091,809 · Class: 3.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000201
- Form type
- SCHEDULE 13G/A
- Filer
- MORGAN STANLEY
- CIK
- CIK 895421
- Filed
- Feb 03, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership